Nephrology Late Breakers (2024)

In this session you will learn:

  • The new breaking trials in the treatment of IgA nephropathy and focal segmental glomerulosclerosis
  • The unique dual action of sparsenten
  • The unique pharmacological mechanism of action features of TRF-Budesonide

Mark D. Baldwin, DO, FACOI

Professor and Chair, Department of Internal Medicine

Pacific Northwest University of Health Sciences

Professor and Chair, Department of Internal Medicine
Pacific Northwest University of Health Sciences
Yakima, Washington

John E. Prior, DO, FACOI

Clinical Associate Professor of Medicine

The Geisinger Commonwealth School of Medicine

Clinical Associate Professor of Medicine
The Geisinger Commonwealth School of Medicine
Scranton, Pa

Key:

Complete
Failed
Available
Locked
Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Webcast
04/11/2024 at 1:15 PM (EDT)  |  Recorded On: 04/11/2024  |  36 minutes
04/11/2024 at 1:15 PM (EDT)  |  Recorded On: 04/11/2024  |  36 minutes
Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Evaluation
15 Questions